Monoclonal antibodies against hemagglutinin of h5-serotype influenza viruses and their uses, hybridomas producing said antibodies, compositions and diagnostic kits
The object of the invention are monoclonal antibodies against hemagglutinin of H5-serotype influenza viruses selected from the group comprising G-1-31-22, G-2-14-10, G-5-32-5, G-6-42-42, G-7-24-17 and G-7-27-18, having a broad application in immunoprophylaxis and immunotherapy of infections evoked by H5-serotype influenza viruses in humans and animals. The invention also provides hybridomas producing said antibodies, as well as compositions and diagnostic kits containing said antibodies for the detection and typing of H5-serotype influenza viruses and antibodies against H5-serotype influenza viruses in biological samples.
1. A monoclonal antibody against hemagglutinin of an H5 serotype influenza virus or an antigen binding fragment thereof, wherein the antibody or antigen binding fragment thereof binds an epitope of H5 antigen, wherein the monoclonal antibody is selected from the group consisting of:
(i) G-1-31-22 produced by mouse hybridoma cell line G-1-31-22 deposited with the DSMZ under the number DSM ACC3292,
(ii) G-2-14-10 produced by mouse hybridoma cell line G-2-14-10 deposited with the DSMZ under the number DSM ACC3293,
(iii) G-5-32-5 produced by mouse hybridoma cell line G-5-32-5 deposited with the DSMZ under the number DSM ACC3294,
(iv) G-6-42-42 produced by mouse hybridoma cell line G-6-42-42 deposited with the DSMZ under the number DSM ACC3295,
(v) G-7-24-17 produced by mouse hybridoma cell line G-7-24-17 deposited with the DSMZ under the number DSM ACC3296, and
(vi) G-7-27-18 produced by mouse hybridoma cell line G-7-27-18 deposited with the DSMZ under the number DSM ACC3297.
2. The monoclonal antibody against hemagglutinin of an H5 serotype influenza virus or an antigen binding fragment thereof according to claim 1 , wherein the antigen binding fragment thereof is selected from the group consisting of Fab, Fab′, F(ab′)2, Fv, VH, VL and single-chain antibody molecules consisting of VL and VH domains bound to each other by peptide linker.
3. The monoclonal antibody according to claim 1 , wherein the hemagglutinin is from an influenza virus of H5 serotype, selected from the group consisting of H5N1, H5N2, H5N3 and H5N9.
4. The monoclonal antibody according to claim 1 , wherein the monoclonal antibody or the antigen binding fragment thereof is conjugated with an analytically detectable label, prodrug, drug, therapeutic agent, peptide, protein, enzyme virus, lipid, or PEG.
5. A mouse hybridoma cell line selected from the group consisting of:
(i) G-1-31-22 deposited with the DSMZ under the number DSM ACC3292,
(ii) G-2-14-10 deposited with the DSMZ under the number DSM ACC3293,
(iii) G-5-32-5 deposited with the DSMZ under the number DSM ACC3294,
(iv) G-6-42-42 deposited with the DSMZ under the number DSM ACC3295,
(v) G-7-24-17 deposited with the DSMZ under the number DSM ACC3296, and
(vi) G-7-27-18 deposited with the DSMZ under the number DSM ACC3297.
6. A pharmaceutical or diagnostic composition comprising the monoclonal antibody against hemagglutinin of an H5 serotype influenza virus or an antigen binding fragment thereof according to claim 1 and a suitable carrier or label.
7. A method for in vitro diagnosis of an influenza virus H5 serotype infection, comprising contacting a biological sample with the monoclonal antibody against hemagglutinin of an H5 serotype influenza virus or an antigen binding fragment thereof, according to claim 1 and detecting binding of said antibody or an antigen binding fragment thereof with H5 serotype influenza virus or H5 hemagglutinin protein.
8. A diagnostic kit for detection of an influenza virus H5 serotype infection, comprising the monoclonal antibody against hemagglutinin of an H5 serotype influenza virus or an antigen binding fragment thereof according to claim 1 , and reagents for detection of said antibody or antigen binding fragment thereof bound with H5 serotype influenza virus or H5 hemagglutinin protein.
9. A diagnostic kit for detection or quantification of an influenza H5 serotype virus in a biological sample, comprising the monoclonal antibody against hemagglutinin of an H5 serotype influenza virus or an antigen binding fragment thereof according to claim 1 .
10. A diagnostic kit for detection or quantification of antibodies against H5 serotype influenza virus in a biological sample, comprising the monoclonal antibody against hemagglutinin of an H5 serotype influenza virus or an antigen binding fragment thereof as defined in claim 1 .
11. A method of performing a test selected from the group consisting of an immunoenzymatic test, an immunofluorescent test, an immunochemiluminescent test, a radioimmunological test, an immunochromatographic test, an immunodiffusion test, and an immunoprecipitation test, comprising using a kit according to claim 8 .
12. A method of performing a test selected from the group consisting of an immunoenzymatic test, an immunofluorescent test, an immunochemiluminescent test, a radioimmunological test, an immunochromatographic test, an immunodiffusion test, and an immunoprecipitation test, comprising using a kit according to claim 9 .
13. A method of performing a test selected from the group consisting of an immunoenzymatic test, an immunofluorescent test, an immunochemiluminescent test, a radioimmunological test, an immunochromatographic test, an immunodiffusion test, and an immunoprecipitation test, comprising using a kit according to claim 10 .
14. The diagnostic kit according to claim 8 , wherein the monoclonal antibody against hemagglutinin of an H5 serotype influenza virus or an antigen binding fragment thereof is purified.
15. The diagnostic kit according to claim 9 , wherein the monoclonal antibody against hemagglutinin of an H5 serotype influenza virus or an antigen binding fragment thereof is purified.
16. The diagnostic kit according to claim 10 , wherein the monoclonal antibody against hemagglutinin of an H5 serotype influenza virus or an antigen binding fragment thereof is purified.